A drug company with the same founders as a compounding pharmacy linked to a meningitis outbreak has agreed to remain closed until at least Feb. 22.
Massachusetts has taken action against three more compounding pharmacies following unannounced inspections that were ordered in the wake of a deadly fungal meningitis outbreak linked to a Framingham pharmacy.
A federal grand jury has begun to hand down subpoenas in its investigation of the deadly meningitis outbreak linked to a Framingham pharmacy.
Massachusetts Health and Human Services Secretary JudyAnn Bigby says state overseers and the managers of a compounding pharmacy bear responsibility for a fatal, nationwide outbreak of fungal meningitis.
The state’s oversight of compounding pharmacies will be the subject of a legislative hearing.
A company spokesman says the notice affects 650 employees at Ameridose and 140 employees at its marketing and support arm.
A company with the same founders as a specialty pharmacy tied to a deadly meningitis outbreak has agreed to extend its voluntary closure until Nov. 19.
A Massachusetts lawmaker says he’ll introduce legislation to increase federal oversight of specialty pharmacies like the one linked to a deadly meningitis outbreak.
A forensic pathologist says an autopsy shows a Kentucky judge’s death was linked to tainted steroid shots at a Tennessee clinic.
The Department of Public Health has revoked the license of another compounding pharmacy in the state.